The only FDA approved therapeutic use of Endothelium-Derived Relaxing Factor is
Pulmonary hypeension in newborn
Primary pulmonary hypeension
Congestive cardiac failure
Essential hypeension in newborn
EDRF is also called nitric oxide. The only approved use is vasodilatation in Pulm.HTN in newborn Ref: Goodman Gillman 12thedPg 1059
All India exam